FindTrial
Sign In

Green tea effect on weight loss and hormone levels in polycystic ovary syndrome

Comparing the effect of green tea and placebo on weight loss, Insulin Resistance Index and Testosterone in overweight and obese patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013111015349N1
Enrollment
Unknown
Registered
2014-01-20
Start date
2013-12-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome. Sclerocystic ovary syndrome

Interventions

Intervention 1: Green Tea Tablets( Green Teadin) from Dinah Industrial Complex of Iran 500 mg 2 times a day for 12 weeks(Tablet powder is poured into capsules). Intervention 2: placebo(Capsules contai
Treatment - Drugs
Green Tea Tablets( Green Teadin) from Dinah Industrial Complex of Iran 500 mg 2 times a day for 12 weeks(Tablet powder is poured into capsules)
placebo(Capsules containing flour) 2 times a day for 12 weeks

Sponsors

Vice chancellor for research, Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: - Infected samples PCOS is registered by the gynecologist. - Persons between the age group of 40-20 years are. Exclusion criteria: -Patients have the History of heart disease - cardiovascular disease, diabetes or other metabolic diseases. -Patients who do not wish to be excluded - Patients with weight loss drugs insulin sensitizer drugs and contraceptive use - Patients who are treated with weight loss diets -Patients engaged in heavy exercise

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Body mass Index. Timepoint: before intervention & 12 weeks after intervention. Method of measurement: weight with one hundred grams and height with 0/5 cm of measurement sensitivity will be measured and BMI by dividing weight in kilograms by the square of height (m) shall be calculated.;Free Testosterone. Timepoint: before intervention & 12 weeks after intervention. Method of measurement: dl- chemenoassay.;Insulin resistance index(HOMA-IR). Timepoint: before intervention & 12 weeks after intervention. Method of measurement: insulin resistance index (HOMA-IR) was measured by the calculation of relevant equation.;Fasting serum glucose. Timepoint: before intervention & 12 weeks after intervention. Method of measurement: enzyme-calorimetric method.;Fasting serum insulin concentrations. Timepoint: before intervention & 12 weeks after intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELIZA) method.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Allahdadian

Isfahan University of Medical Sciences

allahdadian@iaufala.ac.irmaryamallahdadian@yahoo.com+98 31 1792 2927

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026